{"id":247116,"date":"2025-05-31T00:00:00","date_gmt":"2025-05-31T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47031010-medtech-cardiac-rhythm-management-devices-market\/"},"modified":"2026-04-29T23:01:56","modified_gmt":"2026-04-29T23:01:56","slug":"47042167-medtech-cardiac-rhythm-management-devices-market-insights-asia-pacific-supplemental","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042167-medtech-cardiac-rhythm-management-devices-market-insights-asia-pacific-supplemental\/","title":{"rendered":"Cardiac Rhythm Management Devices &#8211; Market Insights &#8211; Asia Pacific (Supplemental)"},"content":{"rendered":"<p>The Asia Pacific CRM device market will experience <span>modest<\/span> growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices, including CRT devices, leadless pacemakers, and <abbr data-abbreviation-entity=\"9672\" title=\"Subcutaneous Implantable Cardioverter Defibrillator\">S-<\/abbr><abbr data-abbreviation-entity=\"9672\" title=\"Subcutaneous Implantable Cardioverter Defibrillator\">ICD<\/abbr>s These advancements will contribute to overall market expansion. However, economic constraints across the region will limit revenue growth to some extent, impacting the widespread adoption of high-cost technologies.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the Asia Pacific CRM device market from 2019 through 2033.<\/p>\n","protected":false},"template":"","class_list":["post-247116","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiac-rhythm-management-devices","medtech-therapy-area-cardiovascular","medtech-geography-asia-pacific","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/247116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/247116\/revisions"}],"predecessor-version":[{"id":467357,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/247116\/revisions\/467357"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=247116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}